Vydura
Active substance: rimegepant
rimegepant
Centralised EU authorisationActive
Marketing holder: Pfizer Europe MA EEIG
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 |
|
| US 3 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-9a15-74d1-b4b6-42e7e72301ba,01a120c3-de20-7aa4-823e-6313b1790c4f;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-67f2-7be8-abeb-41f94f3651fa,01a12095-18fc-7156-a9bb-09e2a38168db,01a1209c-0f66-7714-8699-2b818541562f;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/005725
- Registration status
- Active
- ATC code
- N02CD06
Sources
- product · EMA · EMEA/H/C/005725 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005725 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005725 · Verified 2026-10-09